ProgressingClinical study of [68Ga]Ga-NOTA-SNA002 PET in solid tumors imagining
Phase: Early Phase I
Principal Investigator:
- Zhongshan Hospital
Brief Summary:
To assesse PD-L1 expression in tumor patients and exploring a means to replace Immunohistochemical , to provide personalized treatment options for tumor patients
ProgressingClinical study of 68Ga-PD-L1 PET in solid tumors imagining
Phase: Early Phase I
Principal Investigator:
The First Affiliated Hospital of Soochow University
Brief Summary:
To investigate the safety and tolerability of solid tumor patients after receiving 68Ga-PD-L1 PET, to observe the distribution and metabolism of 68Ga-PD-L1 PET in vivo, and to evaluate the correlation between 68Ga-PD-L1 PET and FDG-PET in locating tumor lesions.